BeStock  
Stocks › Biotechnology › CTMX

CytomX CTMX

US equityMarket cap rank #3673Biotechnology
$2.55 −$0.01 (-0.39%)
Pre-market · Oct 8, 8:20 am ET · After hours $2.54 -0.39%
Open$2.53
Prev close$2.56
Day range$2.52 – $2.65
Volume2.34M
Market cap$555.64M
P/E (TTM)–
Dividend yield–

CTMX Stock News

Headlines matching CytomX or the CTMX ticker, most recent first.

  • Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $12Market news · 23 Sep 2026 · Direct mention
  • Barclays Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $16Market news · 7 Aug 2026 · Direct mention
  • J.P. Morgan Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $11Market news · 17 Aug 2026 · Direct mention
  • J.P. Morgan Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $11 NegativeMarket news · 13 Aug 2026 · Direct mention
  • Wedbush Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $11Market news · 4 Jun 2026 · Direct mention
  • A Quick Look at Today's Ratings for CytomX(CTMX.US), With a Forecast Between $11 to $16Market news · 9 May 2026 · Direct mention
  • Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $15Market news · 8 May 2026 · Direct mention
  • Wolfe Research Initiates CytomX(CTMX.US) With Buy Rating, Announces Target Price $6Market news · 19 May 2026 · Direct mention
  • Oppenheimer Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $12Market news · 13 May 2026 · Direct mention
  • H.C. Wainwright Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $11 NegativeMarket news · 11 May 2026 · Direct mention
  • Cantor Fitzgerald Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $10 PositiveMarket news · 9 Mar 2026 · Direct mention
  • Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $10Market news · 9 Mar 2026 · Direct mention
  • Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $12 PositiveMarket news · 23 Mar 2026 · Direct mention
  • Barclays Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $16 PositiveMarket news · 19 Mar 2026 · Direct mention
  • Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $15 PositiveMarket news · 18 Mar 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on CTMX.

Leave a comment

Scroll to Top